News & Events about Insmed Incorporated.
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., May 5, 2023 BRIDGEWATER, N.J., May 5, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical...
TipRanks Financial Blog
1month ago
Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Insmed (INSM Research Report) today and set a price target of $28.00. The ... Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Insmed (INSM –...
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., April 6, 2023 BRIDGEWATER, N.J., April 6, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical...
Insmed Incorporated (NASDAQ:INSM Get Rating) has been assigned an average rating of Moderate Buy from the thirteen brokerages that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and eleven have issued a buy rating on the company. The ...
Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis PR Newswire BRIDGEWATER, N.J., March 31, 2023 Topline Data Remains on Track to be Reported in...